Quarterly report · Q1
9987.TEDINET S100RMWL
Period2023-04-01 → 2023-06-30
Filed2023-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥573.6bn | 2023-04-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥2.31T | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥553.8bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Operating income | ¥4.1bn | 2023-04-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | ¥3.5bn | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | ¥5.0bn | 2023-04-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥36.4bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.6bn | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥5.1bn | 2023-04-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥4.5bn | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥3.3bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥20.3bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.7bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥3.3bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | ¥2.7bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥1.19T | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥1.15T | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥1.17T | at 2022-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥772.0bn | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥734.6bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥418.1bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥411.5bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥419.3bn | at 2022-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥114.2bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥109.0bn | at 2023-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥40.4 | 2023-04-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥236.47 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥30.49 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 35.1% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.9% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 36.0% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 40
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q1r_E02780-000The Community Healthcare And Nursing Care Support Businessreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥23.9bn |
| jpcrp040300-q1r_E02780-000The Community Healthcare And Nursing Care Support Businessreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥23.9bn |
| jpcrp040300-q1r_E02780-000The Community Healthcare And Nursing Care Support Businessreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥3m |
| jpcrp040300-q1r_E02780-000The Community Healthcare And Nursing Care Support Businessreportable segment | segment profit | 2023-04-01 → 2023-06-30 | −¥38m |
| jpcrp040300-q1r_E02780-000The Healthcare Product Development Businessreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥12.8bn |
| jpcrp040300-q1r_E02780-000The Healthcare Product Development Businessreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥2.9bn |
| jpcrp040300-q1r_E02780-000The Healthcare Product Development Businessreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥9.9bn |
| jpcrp040300-q1r_E02780-000The Healthcare Product Development Businessreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥521m |
| jpcrp040300-q1r_E02780-000The Healthcare Related Services Businessreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥63.8bn |
| jpcrp040300-q1r_E02780-000The Healthcare Related Services Businessreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥7.1bn |
| jpcrp040300-q1r_E02780-000The Healthcare Related Services Businessreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥56.7bn |
| jpcrp040300-q1r_E02780-000The Healthcare Related Services Businessreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥213m |
| jpcrp040300-q1r_E02780-000The Pharmaceutical Distribution Businessreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥553.4bn |
| jpcrp040300-q1r_E02780-000The Pharmaceutical Distribution Businessreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥539.8bn |
| jpcrp040300-q1r_E02780-000The Pharmaceutical Distribution Businessreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥13.7bn |
| jpcrp040300-q1r_E02780-000The Pharmaceutical Distribution Businessreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥3.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-06-30 | ¥653.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-06-30 | ¥573.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥80.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-06-30 | ¥4.0bn |
| jpcrp040300-q1r_E02780-000The Community Healthcare And Nursing Care Support Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥24.0bn |
| jpcrp040300-q1r_E02780-000The Community Healthcare And Nursing Care Support Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥24.0bn |
| jpcrp040300-q1r_E02780-000The Community Healthcare And Nursing Care Support Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥0 |
| jpcrp040300-q1r_E02780-000The Community Healthcare And Nursing Care Support Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥198m |
| jpcrp040300-q1r_E02780-000The Healthcare Product Development Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥11.8bn |
| jpcrp040300-q1r_E02780-000The Healthcare Product Development Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥3.2bn |
| jpcrp040300-q1r_E02780-000The Healthcare Product Development Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥8.6bn |
| jpcrp040300-q1r_E02780-000The Healthcare Product Development Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥613m |
| jpcrp040300-q1r_E02780-000The Healthcare Related Services Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥49.7bn |
| jpcrp040300-q1r_E02780-000The Healthcare Related Services Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥6.9bn |
| jpcrp040300-q1r_E02780-000The Healthcare Related Services Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥42.7bn |
| jpcrp040300-q1r_E02780-000The Healthcare Related Services Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥242m |
| jpcrp040300-q1r_E02780-000The Pharmaceutical Distribution Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥533.5bn |
| jpcrp040300-q1r_E02780-000The Pharmaceutical Distribution Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥519.6bn |
| jpcrp040300-q1r_E02780-000The Pharmaceutical Distribution Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥13.8bn |
| jpcrp040300-q1r_E02780-000The Pharmaceutical Distribution Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥2.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-06-30 | ¥618.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-06-30 | ¥553.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥65.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-06-30 | ¥3.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 344
| Item | Context | Value | Unit |
|---|---|---|---|
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0012 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 100000 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 100000 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.0012 | |
| Cash and deposits | Prior1YearInstant | 109026000000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 114219000000 | JPY |
| Notes and accounts receivable trade | Prior1YearInstant | 521028000000 | JPY |
| Notes and accounts receivable trade | CurrentQuarterInstant | 549822000000 | JPY |
| Short term investment securities | Prior1YearInstant | 83677000000 | JPY |
| Short term investment securities | CurrentQuarterInstant | 77299000000 | JPY |
| Merchandise and finished goods | Prior1YearInstant | 133154000000 | JPY |
| Merchandise and finished goods | CurrentQuarterInstant | 139172000000 | JPY |
| Work in process | Prior1YearInstant | 1708000000 | JPY |
| Work in process | CurrentQuarterInstant | 1656000000 | JPY |
| Raw materials and supplies | Prior1YearInstant | 4506000000 | JPY |
| Raw materials and supplies | CurrentQuarterInstant | 3621000000 | JPY |
| Other ca | Prior1YearInstant | 26279000000 | JPY |
| Other ca | CurrentQuarterInstant | 27980000000 | JPY |
| Allowance for doubtful accounts ca | Prior1YearInstant | -1211000000 | JPY |
| Allowance for doubtful accounts ca | CurrentQuarterInstant | -1167000000 | JPY |
| Current assets | Prior1YearInstant | 878169000000 | JPY |
| Current assets | CurrentQuarterInstant | 912603000000 | JPY |
| Property plant and equipment | Prior1YearInstant | 124827000000 | JPY |
| Property plant and equipment | CurrentQuarterInstant | 124275000000 | JPY |
| Goodwill | Prior1YearInstant | 965000000 | JPY |
| Goodwill | CurrentQuarterInstant | 919000000 | JPY |
| Other ia | Prior1YearInstant | 9999000000 | JPY |
| Other ia | CurrentQuarterInstant | 11194000000 | JPY |
| Intangible assets | Prior1YearInstant | 10965000000 | JPY |
| Intangible assets | CurrentQuarterInstant | 12114000000 | JPY |
| Investment securities | Prior1YearInstant | 93602000000 | JPY |
| Investment securities | CurrentQuarterInstant | 102481000000 | JPY |
| Other ioa | Prior1YearInstant | 39398000000 | JPY |
| Other ioa | CurrentQuarterInstant | 39451000000 | JPY |
| Allowance for doubtful accounts ioa by group | Prior1YearInstant | -865000000 | JPY |
| Allowance for doubtful accounts ioa by group | CurrentQuarterInstant | -863000000 | JPY |
| Investments and other assets | Prior1YearInstant | 132135000000 | JPY |
| Investments and other assets | CurrentQuarterInstant | 141069000000 | JPY |
| Noncurrent assets | Prior1YearInstant | 267927000000 | JPY |
| Noncurrent assets | CurrentQuarterInstant | 277459000000 | JPY |
| Assets | Prior1YearInstant | 1146097000000 | JPY |
| Assets | CurrentQuarterInstant | 1190063000000 | JPY |
| Notes and accounts payable trade | Prior1YearInstant | 666515000000 | JPY |
| Notes and accounts payable trade | CurrentQuarterInstant | 689172000000 | JPY |
| Income taxes payable | Prior1YearInstant | 6971000000 | JPY |
| Income taxes payable | CurrentQuarterInstant | 1733000000 | JPY |
| Provision for bonuses | Prior1YearInstant | 8610000000 | JPY |
| Provision for bonuses | CurrentQuarterInstant | 3344000000 | JPY |
| Provision for loss on anti monopoly act cl | Prior1YearInstant | 9790000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |